| Steven M. Tilles, M.d., Inc. | |
|
2505 Samaritan Dr 405 San Jose CA 95124-4006 | |
| (408) 356-8133 | |
| (408) 356-6923 |
| Full Name | Steven M. Tilles, M.d., Inc. |
|---|---|
| Speciality | Internal Medicine |
| Location | 2505 Samaritan Dr, San Jose, California |
| Authorized Official Name and Position | Steven M. Tilles (PRESIDENT) |
| Authorized Official Contact | 4083568133 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Steven M. Tilles, M.d., Inc. 2505 Samaritan Dr 405 San Jose CA 95124-4006 Ph: (408) 356-8133 | Steven M. Tilles, M.d., Inc. 2505 Samaritan Dr 405 San Jose CA 95124-4006 Ph: (408) 356-8133 |
| NPI Number | 1033482351 |
|---|---|
| Provider Enumeration Date | 02/16/2012 |
| Last Update Date | 02/16/2012 |
| Medicare PECOS PAC ID | 8729249727 |
|---|---|
| Medicare Enrollment ID | O20120419000140 |
News Archive
A day after Haitian President Rene Preval signed a decree authorizing a date for November elections, he rebuffed other recommendations issued by the U.S. Senate, which include "holding an election for his successor, brushing off criticism that the current process will leave the shattered country without a credible leader," the Associated Press reports.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it has initiated an open-label Phase 1b safety and dose escalation clinical trial with INNO-206 at the Sarcoma Oncology Center in Santa Monica, California. The clinical trial will include up to 24 patients with advanced solid tumors who have failed standard therapies.
The experimental drug J147 is something of a modern elixir of life; it's been shown to treat Alzheimer's disease and reverse aging in mice and is almost ready for clinical trials in humans.
Organ transplants save lives, but the story doesn't end when a patient emerges from the operating room. Rejection episodes, in which the immune system rallies against the new organ, can occur.
If detected early, nonmelanoma skin cancers (primarily basal cell and squamous cell carcinomas, the two most common forms of skin cancer) can be easily treated. But when left untreated, these skin cancers can grow and even spread, causing considerably more harm than if they were treated upon initial detection. Now, a new study finds that denial is the top reason why patients delay seeking treatment for skin cancer and shows that this delay results in larger, more serious, skin cancers.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033482351 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Secondary |
| 207RN0300X | Internal Medicine - Nephrology | (* (Not Available)) | Primary |
| Provider Name | Steven Tilles |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1841292745 PECOS PAC ID: 6800971730 Enrollment ID: I20120419000179 |
News Archive
A day after Haitian President Rene Preval signed a decree authorizing a date for November elections, he rebuffed other recommendations issued by the U.S. Senate, which include "holding an election for his successor, brushing off criticism that the current process will leave the shattered country without a credible leader," the Associated Press reports.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it has initiated an open-label Phase 1b safety and dose escalation clinical trial with INNO-206 at the Sarcoma Oncology Center in Santa Monica, California. The clinical trial will include up to 24 patients with advanced solid tumors who have failed standard therapies.
The experimental drug J147 is something of a modern elixir of life; it's been shown to treat Alzheimer's disease and reverse aging in mice and is almost ready for clinical trials in humans.
Organ transplants save lives, but the story doesn't end when a patient emerges from the operating room. Rejection episodes, in which the immune system rallies against the new organ, can occur.
If detected early, nonmelanoma skin cancers (primarily basal cell and squamous cell carcinomas, the two most common forms of skin cancer) can be easily treated. But when left untreated, these skin cancers can grow and even spread, causing considerably more harm than if they were treated upon initial detection. Now, a new study finds that denial is the top reason why patients delay seeking treatment for skin cancer and shows that this delay results in larger, more serious, skin cancers.
› Verified 7 days ago
News Archive
A day after Haitian President Rene Preval signed a decree authorizing a date for November elections, he rebuffed other recommendations issued by the U.S. Senate, which include "holding an election for his successor, brushing off criticism that the current process will leave the shattered country without a credible leader," the Associated Press reports.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it has initiated an open-label Phase 1b safety and dose escalation clinical trial with INNO-206 at the Sarcoma Oncology Center in Santa Monica, California. The clinical trial will include up to 24 patients with advanced solid tumors who have failed standard therapies.
The experimental drug J147 is something of a modern elixir of life; it's been shown to treat Alzheimer's disease and reverse aging in mice and is almost ready for clinical trials in humans.
Organ transplants save lives, but the story doesn't end when a patient emerges from the operating room. Rejection episodes, in which the immune system rallies against the new organ, can occur.
If detected early, nonmelanoma skin cancers (primarily basal cell and squamous cell carcinomas, the two most common forms of skin cancer) can be easily treated. But when left untreated, these skin cancers can grow and even spread, causing considerably more harm than if they were treated upon initial detection. Now, a new study finds that denial is the top reason why patients delay seeking treatment for skin cancer and shows that this delay results in larger, more serious, skin cancers.
› Verified 7 days ago
Chris Chung, Md, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 455 Oconnor Dr, #150, San Jose, CA 95128 Phone: 408-293-7767 Fax: 408-294-6595 | |
Tuan Le, M.d. A Professional Corporation Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1569 Lexann Ave, Suite 122, San Jose, CA 95121 Phone: 408-531-1555 | |
Frank D. Shin, Md, Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1440 S De Anza Blvd, Suite A, San Jose, CA 95129 Phone: 408-366-0405 | |
Verity Medical Foundation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 227 N Jackson Ave, San Jose, CA 95116 Phone: 408-278-3000 | |
Leena Gupta Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4945 Bridgeview Ln, San Jose, CA 95138 Phone: 408-666-0392 | |
Shen Medicine & Pediatrics Assc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 316 Rosewood Ave, San Jose, CA 95117 Phone: 408-296-9800 Fax: 408-296-9805 | |
Terry C. Lin D.o.,inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2520 Samaritan Dr., #201, San Jose, CA 95124 Phone: 888-582-0814 |